DXPP Trademark

Trademark Overview

On Tuesday, February 4, 2025, a trademark application was filed for DXPP with the United States Patent and Trademark Office. The USPTO has given the DXPP trademark a serial number of 99028965. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, February 4, 2025. This trademark is owned by First Ascent Biomedical Inc.. The DXPP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Platform as a service (PAAS) featuring computer software platforms for diagnosing and treating cancer, for individualized cancer treatment planning, for cancer drug selection, and for pharmaceutical drug development.
dxpp

General Information

Serial Number99028965
Word MarkDXPP
Filing DateTuesday, February 4, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, February 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPlatform as a service (PAAS) featuring computer software platforms for diagnosing and treating cancer, for individualized cancer treatment planning, for cancer drug selection, and for pharmaceutical drug development.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 4, 2025
Primary Code042
First Use Anywhere DateThursday, April 11, 2024
First Use In Commerce DateThursday, April 11, 2024

Trademark Owner History

Party NameFirst Ascent Biomedical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33174

Trademark Events

Event DateEvent Description
Tuesday, February 4, 2025NEW APPLICATION ENTERED
Tuesday, February 4, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

dxpp cancer drug treatment individualized planning selection development pharmaceutical treating featuring